1-4 of 4
MB Atkins
Close
Sort by
Journal Articles

Interleukin-6-associated anemia: determination of the underlying mechanism

MB Atkins, K Kappler, JW Mier, RE Isaacs, EM Berkman
Journal: Blood
Blood (1995) 86 (4): 1288–1291.
https://doi.org/10.1182/blood.V86.4.1288.bloodjournal8641288
Published: 1995
Journal Articles

Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55

H Tilg, E Trehu, MB Atkins, CA Dinarello, JW Mier
Journal: Blood
Blood (1994) 83 (1): 113–118.
https://doi.org/10.1182/blood.V83.1.113.113
Published: 1994
Journal Articles

Complement activation in cancer patients undergoing immunotherapy with interleukin-2 (IL-2): binding of complement and C-reactive protein by IL-2-activated lymphocytes

G Vachino, JA Gelfand, MB Atkins, JD Tamerius, P Demchak, JW Mier
Journal: Blood
Blood (1991) 78 (10): 2505–2513.
https://doi.org/10.1182/blood.V78.10.2505.2505
Published: 1991
Journal Articles

Inhibition of interleukin-2-induced tumor necrosis factor release by dexamethasone: prevention of an acquired neutrophil chemotaxis defect and differential suppression of interleukin-2-associated side effects [see comments]

JW Mier, G Vachino, MS Klempner, FR Aronson, R Noring, S Smith, EP Brandon, W Laird, MB Atkins
Journal: Blood
Blood (1990) 76 (10): 1933–1940.
https://doi.org/10.1182/blood.V76.10.1933.1933
Published: 1990